British drug major AstraZeneca Plc.'s COVID-19 vaccine, co-developed by the University of Oxford, has been approved for emergency supply in the UK.
The company is releasing the first doses today so that vaccinations may begin early in the New Year. AstraZeneca aims to supply millions of doses in the first quarter as part of an agreement with the government to supply up to 100 million doses in total.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com